Artroglycan – Syntex

Description

Product Description

INDICATIONS:

Non-infectious arthritis, osteoarthrosis, hydrarthrosis, and other degenerative arthropathies. Polyarthritis is secondary to omphaloflevitis. Osteoarthritis and arthritis of the metacarpophalangeal joint. Tarsal osteoarthritis with periostitis. Navicular disease. The articular effort of the metacarpophalangeal joint. Synovitis and capsulitis of the great sesamoid sheath, among others.

DOSAGE AND DIRECTIONS FOR USE:

Administer a 5 ml dose at intervals of 4 to 7 days, IM route, recommending 5 average applications or more.

FORMULA:

Chondroitin Sulfate